Tuesday, January 18, 2011

A Glimmer of Hope for Personalized Medicine

An editorial in the New England Journal of Medicine discussed the advent of genetic testing for susceptibility to disease, variability of patient response to multiple therapies, and assessment of molecular mechanisms. They called for the need to provide the right dose of the right medicine to the right patient at the right time. This is a welcome change from the cookbook medicine and rigid guidelines of the medical care system now put into place by government programs and insurance companies. Integrative medicine and nutritional therapies have a lot to offer when genetic expression needs to be altered. Hopefully, these will be leaders into the cost-effective medicine of the future.

See NEJM.org (click here), June 15, 2020.

No comments: